Published in J Biol Chem on April 28, 2008
Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell (2009) 11.26
Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 3.70
DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe (2012) 3.23
Many stimuli pull the necrotic trigger, an overview. Cell Death Differ (2011) 2.55
Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol (2011) 2.40
The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol (2015) 2.36
Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem (2013) 2.24
Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2013) 2.10
RIP3: a molecular switch for necrosis and inflammation. Genes Dev (2013) 1.94
Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol (2013) 1.89
DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep (2009) 1.72
Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol (2008) 1.66
The molecular regulation of programmed necrotic cell injury. Trends Biochem Sci (2010) 1.55
Going up in flames: necrotic cell injury and inflammatory diseases. Cell Mol Life Sci (2010) 1.35
Herpes simplex virus suppresses necroptosis in human cells. Cell Host Microbe (2015) 1.32
Viral modulation of programmed necrosis. Curr Opin Virol (2013) 1.20
Feeling manipulated: cytomegalovirus immune manipulation. Virol J (2009) 1.19
Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. J Intern Med (2010) 1.17
RIP kinases: key decision makers in cell death and innate immunity. Cell Death Differ (2014) 1.14
Viral mediated redirection of NEMO/IKKγ to autophagosomes curtails the inflammatory cascade. PLoS Pathog (2012) 1.11
dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ (2012) 1.07
Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death. EMBO Rep (2014) 1.07
Multifaceted evasion of the interferon response by cytomegalovirus. J Interferon Cytokine Res (2009) 1.06
Staying alive: cell death in antiviral immunity. Mol Cell (2014) 1.06
Specific inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143. J Virol (2008) 1.04
Fueling the flames: Mammalian programmed necrosis in inflammatory diseases. Cold Spring Harb Perspect Biol (2012) 1.03
True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol (2014) 0.99
The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages. J Virol (2010) 0.97
Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol (2016) 0.96
Suppression of RIP3-dependent necroptosis by human cytomegalovirus. J Biol Chem (2015) 0.93
Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes. J Virol (2011) 0.93
Necroptosis: The Trojan horse in cell autonomous antiviral host defense. Virology (2015) 0.91
Photoreceptor cell death and rescue in retinal detachment and degenerations. Prog Retin Eye Res (2013) 0.91
Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells. Virol J (2008) 0.90
Live or let die: manipulation of cellular suicide programs by murine cytomegalovirus. Med Microbiol Immunol (2012) 0.90
Manipulation of apoptosis and necroptosis signaling by herpesviruses. Med Microbiol Immunol (2015) 0.88
The ribonucleotide reductase R1 subunits of herpes simplex virus 1 and 2 protect cells against poly(I · C)-induced apoptosis. J Virol (2011) 0.86
Pathogen-mediated proteolysis of the cell death regulator RIPK1 and the host defense modulator RIPK2 in human aortic endothelial cells. PLoS Pathog (2012) 0.86
Prevention of cellular suicide by cytomegaloviruses. Viruses (2012) 0.84
Murine cytomegalovirus virion-associated protein M45 mediates rapid NF-κB activation after infection. J Virol (2014) 0.82
Evolutionary link between metazoan RHIM motif and prion-forming domain of fungal heterokaryon incompatibility factor HET-s/HET-s. Sci Rep (2014) 0.81
Viral inhibition of BAK promotes murine cytomegalovirus dissemination to salivary glands. J Virol (2013) 0.81
A single viral gene determines lethal cross-species neurovirulence of baboon herpesvirus HVP2. Virology (2014) 0.80
Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection. PLoS Pathog (2012) 0.79
Mechanisms of RIPK3-induced inflammation. Immunol Cell Biol (2016) 0.79
A motive for killing: effector functions of regulated lytic cell death. Immunol Cell Biol (2016) 0.79
Functional Comparison of Molluscum Contagiosum Virus vFLIP MC159 with Murine Cytomegalovirus M36/vICA and M45/vIRA Proteins. J Virol (2015) 0.78
RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival. Mol Cell Biol (2015) 0.77
Murine gammaherpesvirus 68 encodes a second PML-modifying protein. J Virol (2013) 0.77
Interplay of autophagy and apoptosis during murine cytomegalovirus infection of RPE cells. Mol Vis (2014) 0.76
Mouse cytomegalovirus M36 and M45 death suppressors cooperate to prevent inflammation resulting from antiviral programmed cell death pathways. Proc Natl Acad Sci U S A (2017) 0.75
RIPK3 in cell death and inflammation: the good, the bad, and the ugly. Immunol Rev (2017) 0.75
Cooperative inhibition of RIP1-mediated NF-κB signaling by cytomegalovirus-encoded deubiquitinase and inactive homolog of cellular ribonucleotide reductase large subunit. PLoS Pathog (2017) 0.75
RIP1 is a central signaling protein in regulation of TNF-α/TRAIL mediated apoptosis and necroptosis during Newcastle disease virus infection. Oncotarget (2017) 0.75
Global Screening of Antiviral Genes that Suppress Baculovirus Transgene Expression in Mammalian Cells. Mol Ther Methods Clin Dev (2017) 0.75
Die Another Day: Inhibition of Cell Death Pathways by Cytomegalovirus. Viruses (2017) 0.75
How do we fit ferroptosis in the family of regulated cell death? Cell Death Differ (2017) 0.75
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science (2003) 17.57
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell (2003) 11.07
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature (2003) 10.97
Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science (2004) 10.77
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol (2000) 8.49
The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity (1998) 7.35
RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol (2004) 5.74
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A (2004) 4.88
Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev (1999) 4.39
Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol (2004) 4.05
RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ (2007) 2.96
A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science (2001) 2.70
Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol (2005) 2.57
The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci (2005) 2.56
Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem (2001) 2.45
Caspase inhibitors promote alternative cell death pathways. Sci STKE (2006) 2.44
RIP3, a novel apoptosis-inducing kinase. J Biol Chem (1999) 2.15
Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol (2003) 2.03
Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol (2007) 1.97
Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol (2004) 1.94
Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr Biol (1999) 1.85
Cytomegalovirus determinant of replication in salivary glands. J Virol (1992) 1.82
Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci U S A (2008) 1.82
Identification of proteins associated with murine cytomegalovirus virions. J Virol (2004) 1.72
Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection. J Gen Virol (1993) 1.51
The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J Virol (2004) 1.50
Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaB. Mol Cell Biol (1999) 1.45
Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity (2006) 1.44
Activation of a pro-apoptotic amplification loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett (2000) 1.38
Murine cytomegalovirus m41 open reading frame encodes a Golgi-localized antiapoptotic protein. J Virol (2003) 1.28
A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other. J Exp Med (1996) 1.23
Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP. Oncogene (2000) 1.17
Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J Virol (1997) 1.09
Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks. Virology (2005) 0.99
Murine cytomegalovirus infection inhibits tumor necrosis factor alpha responses in primary macrophages. J Virol (2003) 0.97
Tumor necrosis factor-alpha-induced apoptosis in murine cytomegalovirus retinitis. Invest Ophthalmol Vis Sci (2007) 0.84
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 7.70
RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature (2011) 6.03
Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 3.70
DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe (2012) 3.23
Activation of innate immunity is required for efficient nuclear reprogramming. Cell (2012) 2.99
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med (2003) 2.75
Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J Virol (2005) 2.48
Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem (2013) 2.24
Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat Med (2002) 2.20
Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol (2003) 2.03
Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol (2007) 1.97
Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol (2004) 1.94
Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner. J Immunol (2012) 1.71
Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol (2008) 1.66
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation (2004) 1.62
Incremental diagnosis method for intelligent wearable sensor systems. IEEE Trans Inf Technol Biomed (2007) 1.62
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation (2006) 1.46
Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol (2003) 1.44
MEDIC: medical embedded device for individualized care. Artif Intell Med (2008) 1.43
Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J Virol (2005) 1.39
Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J Virol (2006) 1.30
Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog (2007) 1.29
Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1β via caspase-8 in dendritic cells. J Immunol (2013) 1.28
Viral modulation of programmed necrosis. Curr Opin Virol (2013) 1.20
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood (2003) 1.19
Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J Virol (2005) 1.16
Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood (2005) 1.15
Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150. J Virol (2008) 1.15
Viral and host control of cytomegalovirus maturation. Trends Microbiol (2012) 1.15
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation (2006) 1.11
Updated guidelines on the management of cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab. Clin Lymphoma Myeloma (2006) 1.09
Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol (2009) 1.09
RNA analysis by biosynthetic tagging using 4-thiouracil and uracil phosphoribosyltransferase. Methods Mol Biol (2008) 1.09
Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes. Immunity (2012) 1.07
Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids. J Virol (2011) 1.05
Protein kinase R mediates intestinal epithelial gene remodeling in response to double-stranded RNA and live rotavirus. J Immunol (2005) 1.02
HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog (2008) 1.00
True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol (2014) 0.99
Gap junctions and connexin hemichannels underpin hemostasis and thrombosis. Circulation (2012) 0.99
The need and challenges for development of an Epstein-Barr virus vaccine. Vaccine (2013) 0.98
Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J Virol (2004) 0.97
Expression of human CXCR2 in murine neutrophils as a model for assessing cytomegalovirus chemokine vCXCL-1 function in vivo. J Interferon Cytokine Res (2004) 0.96
Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model. BMC Dev Biol (2006) 0.95
Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. J Immunol (2006) 0.94
Transcription of true late (γ2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses. J Virol (2013) 0.92
Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation. Blood (2007) 0.92
Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. J Clin Microbiol (2007) 0.92
Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels. Mol Immunol (2011) 0.92
Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilin-dependent pathway specifically in neural stem/progenitor cells. J Virol (2007) 0.92
Context-aware sensing of physiological signals. Conf Proc IEEE Eng Med Biol Soc (2007) 0.92
Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes. J Virol (2013) 0.91
The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion (2009) 0.91
Feline calicivirus p32, p39 and p30 proteins localize to the endoplasmic reticulum to initiate replication complex formation. J Gen Virol (2009) 0.91
Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood (2002) 0.90
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients. PLoS One (2009) 0.90
Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA. J Virol (2005) 0.89
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. Circulation (2011) 0.89
Episodic sampling: towards energy-efficient patient monitoring with wearable sensors. Conf Proc IEEE Eng Med Biol Soc (2009) 0.89
Changes in coronary arterial dimensions early after cardiac transplantation. Transplantation (2007) 0.89
Manipulation of apoptosis and necroptosis signaling by herpesviruses. Med Microbiol Immunol (2015) 0.88
Proteomic analysis of resting and thrombin-stimulated platelets reveals the translocation and functional relevance of HIP-55 in platelets. Proteomics (2009) 0.83
Enabling large-scale ground-truth acquisition and system evaluation in wireless health. IEEE Trans Biomed Eng (2012) 0.83
PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways. FEBS Lett (2009) 0.82
Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein. Virology (2008) 0.82
Antiviral T cell response triggers cytomegalovirus hepatitis in mice. J Virol (2012) 0.82
Context-driven, prescription-based personal activity classification: methodology, architecture, and end-to-end implementation. IEEE J Biomed Health Inform (2013) 0.81
Inhibition of 2',5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product. J Virol (2011) 0.80
Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway. Virology (2012) 0.80
Highly acidic C-terminal region of cytomegalovirus pUL96 determines its functions during virus maturation independently of a direct pp150 interaction. J Virol (2014) 0.79
CARER: efficient dynamic sensing for continuous activity monitoring. Conf Proc IEEE Eng Med Biol Soc (2011) 0.79
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus. Transplantation (2008) 0.79
Personalized Multilayer Daily Life Profiling Through Context Enabled Activity Classification and Motion Reconstruction: An Integrated System Approach. IEEE J Biomed Health Inform (2014) 0.79
Measurements of tibial rotation during a simulated pivot shift manoeuvre using a gyroscopic sensor. Knee Surg Sports Traumatol Arthrosc (2014) 0.78
Analysis of protein networks in resting and collagen receptor (GPVI)-stimulated platelet sub-proteomes. Proteomics (2011) 0.78
Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. J Heart Lung Transplant (2007) 0.78
Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis. Virology (2013) 0.77
Integrated inertial sensors and mobile computing for real-time cycling performance guidance via pedaling profile classification. IEEE J Biomed Health Inform (2014) 0.76
Cytomegalovirus and heart transplant atherosclerosis: a likely guilt hidden by weak proofs. Transplantation (2004) 0.75
Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. Clin Infect Dis (2008) 0.75
Mechanisms modulating immune clearance during human cytomegalovirus latency. Proc Natl Acad Sci U S A (2012) 0.75
Energy-efficient context classification with dynamic sensor control. IEEE Trans Biomed Circuits Syst (2012) 0.75
[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome]. G Ital Cardiol (Rome) (2007) 0.75
The integration of proteomics and systems approaches to map regulatory mechanisms underpinning platelet function. Proteomics Clin Appl (2013) 0.75
Natural antisense transcripts of UL123 packaged in human cytomegalovirus virions. Arch Virol (2013) 0.75